The high cost of branded GLP-1 medications, which range from $936 to $1,349 per month before insurance and about $1,000 for uninsured patients, presents a significant financial barrier for many individuals
Conceio EM, Mitchell JE, Machado PPP, Vaz AR, Pinto-Bastos A, Ramalho S, et al
Chronic administration of high doses of oral levocarnitine in patients with severely compromised renal function or in ESRD patients on dialysis may result in accumulation of the potentially toxic metabolites, trimethylamine, and trimethylamine-N-oxide, since these metabolites are normally excreted in the urine
F.WagnerD
Wegovy stands out as a leading injectable, used for weekly administration through a user-friendly device